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Abstract The distinction between serrated polyps of the
colon is complex, particularly between hyperplastic polyps
(HP) and sessile serrated adenomas (SSA). Recent data show
that SSA might be the precursors of serrated colonic cancers,
underlining the necessity of identifying them. We character-
ized the demographic and pathologic characteristics of 102
serrated lesions among 321 polyps of the colorectum and
determined if SSA can be microscopically distinguished
from HP in biopsy material of a daily practice. There were 81
HP (79%) and 7 SSA (7%) of which one displayed low-
grade dysplasia. Only six serrated polyps (6%) could not be
correctly classified. The main architectural criteria for
distinguishing SSA from HP is the serrated feature along
the crypt axis and the rarity of undifferentiated cells in the
lower third of the crypts. SSA was significantly more often
located in the right colon and larger (median, 11 vs 4 mm)
than HP. SSA are rare serrated polyps that can be
distinguished from HP based on their morphology, location
in the right colon, and larger size. One SSA of our series
showed low-grade dysplasia supporting the concept that this
lesion might be a precursor of serrated adenocarcinoma.
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Introduction
Until recently, serrated non-adenomatous polyps of the
colon were diagnosed as hyperplastic polyps (HP) and
considered as innocuous and benign lesions without play-
ing a significant role in carcinogenesis [12, 13, 27].
However, over the past several years, serrated polyps have
been the focus of morphologic and critical reappraisal.
In 1996, Torlakovic and Snover [25] published a
reappraisal of HP occurring in the context of hyperplastic
polyposis and proposed that these polyps should be
classified as sessile serrated adenomas (SSA). Some authors
considered SSA as “aggressive” HP and precursors of
serrated colonic cancer [5, 8, 14]. Recently, Snover et al.
[23] reported a detailed morphologic and molecular review
about serrated polyps of the large intestine and defined
morphologic criteria to distinguish HP from SSA. A
nomenclature has been proposed by this group but to date
there is no consensus for the adoption of an unanimous
terminology and classification of SP.
The aim of the current study was to characterize morpho-
logically and demographically a series of serrated polyps
focusing particularly on the distinction between SSA and HP.
We tested the reproducibility of Snover’s histological criteria
of serrated polyps and their applicability in a daily practice,
particularly when dealing with SSA, a serrated lesion that
should be recognized because of its potential implication in
the “serrated neoplasia pathway” [1, 9, 11].
Material and methods
Samples
The biopsy specimens of polyps collected consecutively
from November 2005 to January 2006 were provided from
the Department of Pathology archives in Lausanne, Switzer-
land. All the polyps obtained by colonoscopic polypectomy
were included in the initial assessment. We retrospectively
Virchows Arch (2007) 450:613–618
DOI 10.1007/s00428-007-0413-8
D. Sandmeier :W. Seelentag :H. Bouzourene (*)
Institute of Pathology, Centre Hospitalier Universitaire Vaudois,
Bugnon 25,
CH 1011 Lausanne, Switzerland
e-mail: Hanifa.Bouzourene@chuv.ch
examined 321 polyps of the large intestine from 200 patients,
and 102 serrated polyps were selected from this series. For
morphological analysis, all the polyps were sectioned in an
identical way, and three levels were routinely examined. All
the polyps were examined, including the superficially and
tangentially oriented specimen, to have an overview about
the reality of a routine and daily practice. The resection of the
polyp in one-piece (polypectomy) vs in multiple biopsies
was recorded. Microscopic characteristics of the polyps were
assessed in a double-headed microscope by two observers
involved in the gastrointestinal (GI) tract (D.S. and H.B.).
The observers were blinded as to the location of the biopsies
because knowledge of the site of the polyp might lead to a
bias in the interpretation of the histopathologic findings.
When there were disagreements between the two observers
as to the interpretation of some histologic characteristics and/
or classification of a polyp, the case was re-examined and a
consensus was obtained. The location, number, and size of
the serrated polyps, and the number of samples for each
serrated polyp were recorded. The location of colorectal
serrated polyps was divided into two groups: right colon
(including the splenic flexure) and left colon (descending
colon, sigmoid and rectum). The size of the polyps was
obtained either from the endoscopist’s measurements or from
the macroscopic size of the specimen when the clinician did
not mention the measure.
Morphologic classification of polyps
The diagnosis of traditional serrated adenoma (TSA) was
based on the criteria established by Longagre and Fenoglio-
Preiser [5], combining the serrated glandular pattern of an HP
and dysplasia. The Snover’s criteria were used to separate HP
from SSA and to subdivide HP into three types according to
their amount of mucin (i.e., microvesicular, goblet-cell-rich,
and mucin-poor). The diagnosis of mixed serrated polyp was
considered if there was an admixture of an adenoma and a
serrated polyp. For all serrated polyps, the following
histological features were evaluated: location of the serrated
appearance (limited to the superficial half of the crypts vs the
complete length of the crypts), branching, horizontalization of
the crypts (L shaped), dilatation or narrowing of the base of
the crypts, and crypt herniation through the muscularis
mucosae. Presence of epithelial tufts, foci of pseudostratifi-
cation of the surface epithelium, cytoplasmic eosinophilia,
and dysplasia were also recorded. The different types of crypt
cells were assessed (i.e., goblet cells, gastric foveolar, and
undifferentiated cells) and scored semi-quantitatively as
follows: + if the number was ≤30%, ++ if the number was
>30 and ≤60%, and +++ if the number was >60%.
For the second assessment of the serrated polyps, we
required, as minimal criteria for the diagnosis of SSA, a
serrated pattern throughout the entire length of the crypts
and the absence or rarity of undifferentiated cells in the
lower third of the crypts. Dilatation of crypts was
considered as a minor criterion for the diagnosis of SSA,
particularly in tangential or superficial samples, because it
was often found in the upper part of the crypts in HP. In
poorly orientated or superficial samples, criteria such as
branching, herniation, or horizontalization of the crypts
could frequently not be assessed. Therefore, we decided to
classify a serrated polyp containing more than 30% of
undifferentiated cells as HP. If the above-described minimal
criteria for diagnosis of SSA could not be assessed in a
serrated polyp and if it contained less than 30% undiffer-
entiated cells, then it remained classified as HP vs SSA.
Statistical analysis
Correlations between HP and SSA were assessed using the
Fisher’s exact test for categorical variables (sex, site,
pseudostratification) and the Mann–Whitney test for con-
tinuous variables (age and size). All statistical significance
tests were two-tailed, and significance was set at p<0.05.
Statistical analyses were carried out by means of the
software Statistical Package for the Social Sciences (SPSS)
version 14 for PC (SPSS, Chicago, IL, USA).
Results
One hundred two (32%) serrated polyps were selected from
a series of 321 polyps obtained from 200 patients. Thirty-
six biopsies (35%) were superficial (i.e., above the
muscularis mucosae) or tangentially oriented, whereas 66
(65%) biopsies were well oriented. Nine polyps were
resected in one piece (polypectomy) and 93 polyps in
multiple fragments. During the first histologic assessment,
the 102 serrated polyps were classified as follows: 58 HP
(Fig. 1a,b); 7 SSA (Fig. 2a–d), of which one presented
small foci of low-grade dysplasia (Fig. 3); 5 TSA, and 3
mixed polyps (i.e., HP and tubular adenoma). Twenty-nine
remaining polyps (28%) were serrated lesions but a more
precise diagnosis could not be made on the first histologic
review because the biopsy specimens were either small (all
measured less than 5 mm) or superficial or tangentially
oriented. Moreover, all of them were resected in multiple
fragments (between 3–5), rendering the morphologic
analysis more difficult. In these cases, the architectural
features of either HP or SSA were difficult to be assessed.
After a second review of the 29 not-otherwise-specified
serrated lesions (HP vs SSA), 23 serrated polyps were
reclassified as HP because the proliferative zone lined by
more than 30% of undifferentiated cells was recognizable,
even on poorly oriented biopsies. The differential diagnosis
between HP and SSA remained unsolved in six cases (6%).
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The seven SSA were all resected in one piece, which
facilitated the diagnosis, and their morphologic characteristics
are detailed in Table 1. In all of them, the crypts were mainly
composed of goblet-cell-rich cells with rare or absence of
undifferentiated cells. Dilatation, horizontalization, branch-
ment of the crypts, and herniation of the crypts through the
muscularis mucosae were often combined in the same lesion
in the majority of SSA. Crypt herniation was less frequently
seen than branchment or horizontalization. In three SSA, we
found that some areas of the polyps were reminiscent of HP,
but we did not consider these polyps as mixed serrated
polyps because the foci of HP were too small.
Morphological differences between HP and SSA are
summarized in Table 2. Branching, L-shaped, and hernia-
tion of the crypts are the most useful criteria to distinguish
HP from SSA.
There was a statistically significant difference in site and
size between HP and SSA (Table 3). HP were preferentially
located in the left colon and rectum (n=60, 74%), whereas
most SSA (n=5, 71%) were located in the right colon (p=
Fig. 2 a–d Low and high pow-
er view of a SSA. Crypts are
serrated from their base to the
surface (a), are branched (b),
and present herniation through
the muscularis mucosae (c).
Some of the surface of SSA is
lined with tufted surface, and
cells might be eosinophilic with
pseudostratified nuclei (d)
Fig. 1 a, b Low and high
power view of a hyperplastic
polyp. The crypts are serrated
only at the surface (a), and the
base of the crypts is narrow,
lined predominantly with
undifferentiated cells (b)
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0.002, Fisher exact test). HP were smaller (median, 4 mm)
than SSA (median, 11 mm) in a highly significant manner
(p<0.001, Mann–Whitney test). Interestingly, the polyps in
the category of indefinite diagnosis (HP/SSA) had the
smallest median size (−2.5 mm). There was no significant
difference between HP and SSA with regard to age
(median, 61 vs 57 years, p=0.2). The sex ratio was also
not statistically different between HP and SSA (p=0.4).
Discussion
Traditionally, the two principal categories of colorectal
polyps have been adenomas and HP. Conventional adeno-
mas are well-identified precursor lesions of the tumor
suppressor pathway first proposed by Vogelstein et al. [26].
In contrast, HP have been considered as benign and
innocent mucosal lesions for many years, with no involve-
ment in colonic carcinogenesis [12, 13, 27]. However,
reassessment of the HP through clinical and epidemiolog-
ical reports combined with the genetic alterations has led to
a reinterpretation of its significance in colorectal carcino-
genesis [13, 15]. The serrated polyps demonstrate a “saw-
toothed” infolding of the crypt epithelium, probably as a
consequence of inhibition of programmed cellular apoptosis
of the surface mucosa or more precisely of anoïkis, which is
the inhibition of programmed cell exfoliation, leading to
prolonged cell life [15]. But to date, no consensus has been
established about what classification or nomenclature to use
when dealing with serrated polyps. SSA has been described
by Torlakovic and Snover in 1996 [25] but has been
ignored for several years and designated with different
names, rendering this entity quite confusing. Recently,
Snover et al. [23] reported an excellent morphologic and
molecular review about serrated polyps of the large
intestine.
In the present study, we tested the ease of use of this
classification on the basis of the described morphological
aspects and tried to apply them to the daily practice. We
found that the incidence of SSA is very low, as they
represent 7% of the serrated polyps and only 2% of all
colonic polyps of our series, which is in the range of
previously published data [10]. The distinction between HP
and SSA was based mainly on architectural features, which
seem to be due to abnormal proliferation and probably also
decreased apoptosis [24]. These architectural features can
be better recognized when a well-oriented polypectomy has
been performed. We found that the diagnostic was more
difficult when the biopsy specimens were superficial and
tangentially cut, when the polyp was addressed fragmented,
and when the polyp was small. However, even if the
orientation of the biopsy was not optimal, we could
distinguish between HP and SSA in the majority of the
cases (94%) mainly due to the presence of a great number
of undifferentiated cells in the lower third of HP crypts,
contrasting with the predominance of goblet or gastric
foveolar cells in SSA. Only in six polyps, the differential
diagnosis between HP and SSA could not be resolved due
Table 1 Morphologic characteristics of SSA of the colon
SSA
cases
Crypt
serration
Crypt
branching
L-shaped
crypt
Crypt
dilatation
Crypt
herniation
Nuclear pseudo-
stratification
Cell
eosinphilia
Dysplasia Goblet
cells
Gastrin
cells
Undifferentiated
cells
1 1 1 1 1 1 1 0 0 +++ + 0
2 1 1 1 1 1 1 1 0 +++ ++ +
3 1 0 1 1 0 0 0 0 +++ + 0
4 1 1 1 1 0 0 0 1 +++ ++ +
5 1 1 1 1 1 1 0 0 +++ ++ +
6 1 0 0 1 0 0 0 0 +++ ++ 0
7 1 1 0 1 0 0 0 0 +++ ++ +
SSA Sessile serrated adenoma, 0 absent, 1 present, + < than 30% of the cells, ++ < than 60% of the cells, +++ > than 60% of the cells
Fig. 3 SSA with dysplastic foci
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to the above-mentioned reasons. The fact that the polyps in
the category of indefinite diagnosis (HP/SSA) had the
smallest median size (−2.5 vs 4 and 11 mm for the HP and
SSA, respectively) appears to indicate that the size of the
polyp is an important factor in the distinction of SSA from
HP. The smaller the lesion, the more SSA and HP
histologically overlap. Intermingling features of HP and
SSA in a same serrated polyp, which was observed in three
out of seven SSA, might add more difficulty to the
distinction between both types of lesions. These findings
support the idea that serrated polyps might constitute a
continuous spectrum of lesions.
We found that the absence or presence of undifferenti-
ated cells, location of the serration, branchment, horizon-
talization, and herniation of the crypts appeared to be good
discriminators between HP and SSA.
Beside size and morphological features, other parameters
seem to be discriminators between HP and SSA. HP are
reported to be more frequently located in the distal colon
and rectum [3, 6, 10]. Our results are in agreement with
these data because we found that the majority of HP were
left sided, whereas most SSA were right sided.
For Snover et al. [23], cytological dysplasia is not needed
for the diagnosis of SSA, which is in contradiction with the
generally accepted consensus about diagnostic criteria in
gastrointestinal adenomas. Therefore, some authors do not
fully agree with this concept and prefer to label SSA as
“atypical HP” or “sessile serrated polyp” [2]. However, in
our series, we found one case of SSA showing a low-grade
dysplasia, and recently, Goldstein [5] reported eight cases
of SSA with incidental high-grade dysplasia or invasive
adenocarcinoma. This supports that dysplasia may emerge
in SSA and that they are probably precursors of the serrated
adenocarcinoma [21]. Molecular studies will probably be
able to elucidate the link between morphologic features and
molecular changes. Serrated mucosal lesions of the color-
ectum have emerged as an important concept supporting the
existence of an alternate polyp–neoplasia pathway in
addition to the classical adenoma–carcinoma sequence [1,
7, 9, 11, 26]. The most common genetic changes seem to be
BRAF-activating mutation and CpG island mutation [1, 4,
10, 17, 18, 20, 22]. However, most of the molecular results
already published have to be interpreted with caution
because the serrated polyps studied were heterogeneous
and the diagnostic criteria were poorly defined [4, 6, 17,
19]. To our knowledge, only one recent study analyzed the
molecular features of morphologically well-defined serrated
polyps of the colorectum [16]. However, molecular studies
will be helpful only when a consensual classification will
be established to be sure to study specific morphologic sub-
types of SP and not a broad range of lesions.
In summary, SSA has clinic and morphologic features
distinctive from that of HP. In our view, correct morpho-
logic identification of SSA is essential to enable further
studies that are required to assess molecular basis and
clinical impact of these lesions.
Table 3 Clinical characteris-
tics of hyperplastic polyps and
SSA out of 102 serrated polyps
of the colon
Numbers in parentheses are
percentages within the same
diagnostic category.
HP Hyperplastic polyp, SSA
sessile serrated adenoma,
n number of polyps
HP SSA p value
Total number of polyps 81 7
Percent of all polyps 79 7
Age (years) Median 61 57 0.2
25th percentile 56 46
75th percentile 65 62
Sex (n, %) Male 41 (51%) 2 (29%) 0.4
Female 40 (49%) 5 (71%)
Site (n, %) Right colon 19 (24%) 5 (71%) 0.002
Left colon 27 (33%) 2 (29%)
Rectum 33 (41%) 0
Unknown 2 (2%) 0
Size (mm) Median 4 11 <0.001
25th percentile 2 8
75th percentile 5.2 12
Table 2 Morphologic differ-
ences between 81 hyperplastic
polyps and 7 SSA
SSA Sessile serrated adenoma,
HP hyperplastic polyps
Crypt
branching
(%)
L-shaped
crypt
(%)
Crypt
dilatation
(%)
Crypt
herniation
(%)
Epithelial
tufts (%)
Nuclear
pseudo-
stratification
(%)
Cytoplasmic
eosinophilia
(%)
SSA 71 71 100 43 43 43 14
HP 5 0 27 0 17 14 4
Virchows Arch (2007) 450:613–618 617
References
1. Chan TL, Zhao W, Leung SY, Yuen ST (2003) BRAF and KRAS
mutations in colorectal hyperplastic polyps and serrated adenomas.
Cancer Res 63:4878–4881
2. Cunningham KS, Riddell RH (2006) Serrated mucosal lesions of
the colorectum. Curr Opin Gastroenterol 22:48–53
3. Di Sario JA, Foutch PG, Mai HD (1991) Prevalence and malignant
potential of colorectal polyps in asymptomatic, average-risk men.
A. J Gastroenterol 86:941–945
4. Dong SM, Lee EJ, Jeon ES, Park CK, Kim KM (2005)
Progressive methylation during the serrated neoplasia pathway
of the colorectum. Mod Pathol 18:170–178
5. Goldstein NS (2006) Small colonic microsatellite unstable
adenocarcinomas and high grade epithelial dysplasias in sessile
serrated adenoma polypectomy specimen. A study of eight cases.
Am J Clin Pathol 1:132–145
6. Goldstein NS, Bhanot P, Odish E, Hunter S (2003) Hyperplastic-
like colon polyps that preceded microsatellite unstable adenocar-
cinomas. Am J Clin Pathol 119:778–796
7. Golstein NS (2006) Serrated pathway and APC (conventional)-
type colorectal polyps: molecular-morphologic correlations,
genetic pathways, and implications for classification. Am J Clin
Pathol 1:146–153
8. Hamilton SR (2001) Origin of colorectal cancers in hyperplastic
polyps and serrated adenomas: another truism bites the dust. J
Natl Cancer Inst 5:93.1282–93.1283
9. Hawkins NJ, Bariol C, Ward RL (2002) The serrated neoplasia
pathway. Pathology 34:548–555
10. Higuchi T, Sugihara K, Jass JR (2005) Demographic and
pathological characteristics of serrated polyps of colorectum.
Histopathology 47:32–40
11. Huang CS, O’Brien MJ, Yang S, Farraye FA (2004) Hyperplastic
polyps, serrated adenomas and the serrated polyp neoplasia
pathway. Am J Gastroenterol 99:2242–2255
12. Jass JR (2001) Hyperplastic polyps of the colorectum—innocent
or guilty? Dis Colon Rectum 44:163–166
13. Jass JR, Whitehall VL, Young J, Leggett BA (2002) Emerging
concepts in colorectal neoplasia. Gastroenterology 123:862–876
14. Jass JR (2003) Serrated adenoma of the colorectum. A lesion with
teeth. Am J Pathol 162:705–708
15. Jass JR (2002) Pathogenesis of colorectal cancer. Surg Clin North
Am 82:891–904
16. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D,
Young J (2006) Advanced colorectal polyps with the molecular
and morphological features of serrated polyps and adenomas:
concept of a “fusion” pathway to colorectal cancer. Histopathology
49:121–131
17. Kambara T, Simms LA, Whitehall VLJ, Spring KJ, Wynter CVA,
Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N,
Tanaka N, Higuchi T, Young, Jass JR, Leggett BA (2004) BRAF
mutation is associated with DNA methylation in serrated polyps
and cancers of the colorectum. Gut 53:1137–1144
18. Konishi K, Yamochi T, Makino R, Kaneko K, Yamamoto T, Nozawa
H, Katagiri A, Ito H, Nakayama K, Ota H, Mitamura K, Imawari M
(2004) Molecular differences between sporadic serrated and conven-
tional colorectal adenomas. Clin Cancer Res 10:3082–3090
19. Lazarus R, Junttila OE, Karttunen TJ, Mäkinen MJ (2005) The
risk of metachronous neoplasia in patients with serrated adenoma.
Am J Clin Pathol 123:349–359
20. Lee EJ, Choi C, Park CK, Maeng L, Lee J, Lee A, Kim KM
(2005) Tracing origin of serrated adenomas with BRAF and
KRAS mutations. Virchows Arch 3:597–602
21. O’Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA,
Amorosino M, Swan N (2004) Hyperplastic (serrated) polyps of
the colorectum: relationship of CpG island methylator phenotype
and K-ras mutation to location and histologic subtype. Am J Surg
Pathol 28:423–434
22. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT (2003)
Frequent CpG island methylation in serrated adenomas of the
colorectum. Am J Pathol 162:815–822
23. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP (2005) Serrated
polyps of the large intestine. A morphologic and molecular review
of an evolving concept. Am J Clin Pathol 124:380–391
24. Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T
(2002) Apoptosis index and apoptosis—related antigen expression in
serrated adenoma of the colorectum0: the saw-toothed structure may
be related to inhibition of apoptosis. Am J Surg Pathol 26:249–256
25. Torlakovic E, Snover DC (1996) Serrated adenomatous polyposis
in humans. Gastroenterology 110:748–755
26. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC,
Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988)
Genetic alterations during colorectal tumor development. N Engl J
Med 319:525–532
27. Wynter CVA, Walsh MD, Higuchi T, Leggett BA, Young J, Jass
JR (2004) Methylation patterns define two types of hyperplastic
polyp associated with colorectal cancer. Gut 3:573–580
618 Virchows Arch (2007) 450:613–618
